BlendCJC-1295 / Ipamorelin (No DAC)
CJC-1295 (without DAC) with Ipamorelin
A blended research vial combining modified GRF (1-29) with the selective growth hormone secretagogue ipamorelin.
Choose how to buy
Subscribe & save 5% on reshipsYour first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.
$50.00per vial · 5/5mg
Third-party tested · Purity ≥99% · For laboratory research use only.
- Purity
- ≥99%
- Form
- Powder (lyophilized blend)
- Available sizes
- 5/5mg
Mechanism of Action
CJC-1295 acts as a GHRH analogue on pituitary somatotrophs while ipamorelin acts on the ghrelin receptor, studied together for synergistic GH release in models.
Research Areas
- ●Growth hormone axis research
- ●Recovery and body composition models
- ●Sleep architecture studies




